SARS-CoV-2-IN-39

TargetMol
Product Code: TAR-T77516
Supplier: TargetMol
CodeSizePrice
TAR-T77516-1mg1mg£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T77516-5mg5mg£166.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T77516-10mg10mg£211.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T77516-25mg25mg£307.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T77516-50mg50mg£426.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T77516-100mg100mg£595.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T77516-500mg500mg£1,187.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 uM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
CAS:
2882823-03-0
Molecular Weight:
349.67
Pathway:
Microbiology/Virology|Immunology/Inflammation
Purity:
0.9951
SMILES:
O=C(NC1=CC=C(OC(F)(F)F)C=C1)C2=CC(Cl)=C(F)C=C2O
Target:
Antiviral|SARS-CoV

References

Li R, et al. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2. Eur J Med Chem. 2023;253:115320.